Delivery Order SPE2DB22D9239-SPE2DB25FDL73
- Not listed
- The Defense Logistics Agency awarded a $2,513.56 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Eylea 2 mg/0.05 ml vials. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a specialized pharmaceutical procurement under DLA's broader pharmaceutical supply mission. This award carries no set-aside designation,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of EYLEA 2 mg/0.05 ml vials totaling $25,135.40. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The award carries...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for EYLEA HD 8 MG/0.07 ML vials with a ceiling value of $39,625.20. This firm fixed-price delivery order, awarded on September 3, 2025, represents a single supply requisition under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,925.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a specialized pharmaceutical product, with a period of performance through April 8, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS...
- The Defense Logistics Agency awarded a $5,027.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml vials. The contract, with an ultimate completion date of September 25, 2025, was issued without set-aside designation, allowing DMS to compete on its merits as a small business in the federal pharmaceutical marketplace. This delivery order falls under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 for EYLEA HD 8 mg/0.07 ml vials on September 3, 2025. The contract, which carries no set-aside designation, calls for delivery by September 24, 2025, and is funded through the Defense Logistics Agency's Medical Supply Chain program. This delivery order represents a single purchase of a specialized pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,940.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, which has a completion date of July 18, 2024, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product used to treat certain medical conditions. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $198,126 by the Defense Logistics Agency on August 19, 2025. The delivery order is for EYLEA HD 8 mg/0.07 ml vial medication, with an ultimate completion date of September 10, 2025. This award carries no set-aside designation, allowing the vendor to compete on an unrestricted basis despite its small business status. The place...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml syringes valued at $9,778.40. The award was made on September 10, 2025, with an ultimate completion date of October 1, 2025, under a firm fixed-price delivery order contract with no set-aside designation. Performance will take place at the contractor's Park Ridge facility. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,667.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 mL syringes. This firm fixed-price delivery order, issued on July 30, 2025, is scheduled for ultimate completion by August 20, 2025, with performance taking place in Park Ridge, Illinois. The contract carries no set-aside designation, allowing DMS Pharmaceutical...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL73Delivery Order
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 10, 2025, for the supply of EYLEA HD 8 mg/0.07 mL vials valued at $198,126.00. This firm fixed-price delivery order, with an ultimate completion date of October 1, 2025, carries no set-aside designation. The award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at approximately $500 million and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities. The place of performance is Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has established itself as a critical supplier within the federal pharmaceutical supply chain. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems nationwide. This award for EYLEA HD vials—an injectable pharmaceutical product—is consistent with the company's portfolio of pharmaceutical delivery orders to DLA, which encompasses an extensive array of medical products including specialty medications, injections, and biologics. The company's established presence in federal procurement, coupled with its woman-owned small business status, has enabled it to secure multiple contracts without specific set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $198.1k | 9/10/25 |